Beyond Weight Loss: The Surprising GLP-1 Side Effect You Need to Know 📸 Image Credit: NewsNation By Azeem-USA · Mon Aug 24 2026 English (en-US) The landscape of metabolic health and weight management has been dramatically reshaped by the advent of GLP-1 receptor agonists. Initially developed to manage type 2 diabetes, these revolutionary drugs have captured global attention for their remarkable efficacy in promoting significant weight loss. However, as research deepens and real-world data accumulates, a fascinating and unexpected benefit is beginning to surface, extending far beyond the scale. At Azeem USA, we are committed to bringing you the most pertinent health news and insights. This post delves into a surprising new understanding of GLP-1s, exploring a potential cognitive benefit that could redefine their therapeutic potential and impact millions of lives in ways previously unimagined. 📑 Table of Contents Understanding GLP-1 Agonists The C...
Michael Burry's AI Bet: Is the 'Big Short' Investor Right Again? 📸 Image Credit: Business Insider By Azeem-USA · Tue Aug 04 2026 English (en-US) Michael Burry, the financial oracle who famously profited from the 2008 housing market collapse, has once again captured Wall Street's attention. Known for his contrarian approach and deep market insights, Burry's latest maneuvers often signal significant shifts or vulnerabilities in the market. Recent filings reveal his Scion Asset Management has taken substantial short positions against major AI chip stocks, a move that has sent ripples through an industry currently riding a wave of unprecedented optimism. This bold bet against the seemingly unstoppable rise of artificial intelligence hardware raises critical questions. Is Burry seeing something others are missing? Is the current AI euphoria a bubble waiting to burst, or is this simply a calculated risk by a master investor? At Azeem ...